Roivant Sciences (ROIV) Other Operating Expenses (2020 - 2025)

Roivant Sciences has reported Other Operating Expenses for 6 years, with the latest figure at $700000.0 in Q4 2025.

• For the quarter ending Q4 2025, Other Operating Expenses rose 170.27% year-over-year to $700000.0; the trailing twelve-month figure through Mar 2026 stood at $965000.0 (up 36.69% YoY), and the FY2026 full-year result was $1.3 million, up 41.05% from the prior year.
• Other Operating Expenses for Q4 2025 stood at $700000.0, up from $111000.0 in the prior quarter.
• The five-year high for Other Operating Expenses was $16.7 million in Q2 2023, with the low at $111000.0 in Q3 2025.
• Historically, Other Operating Expenses has averaged $3.2 million across 5 years, with a median of $259000.0 in 2024.
• Annual changes were most pronounced in 2023 — Other Operating Expenses soared 868.37% — and 2024, when it plunged 98.73%.
• Roivant Sciences' Other Operating Expenses stood at $853000.0 in 2021, then soared by 102.34% to $1.7 million in 2022, then sank by 88.59% to $197000.0 in 2023, then surged by 31.47% to $259000.0 in 2024, then jumped by 170.27% to $700000.0 in 2025.
• The last three Other Operating Expenses figures came in at $700000.0 (Q4 2025), $111000.0 (Q3 2025), and $154000.0 (Q2 2025), per Business Quant data.